161 related articles for article (PubMed ID: 35832845)
1. Exosomal miRNA Expression Profiling and the Roles of Exosomal miR-4741, miR-32, miR-3149, and miR-6727 on Gastric Cancer Progression.
Tang G; Wang J; Dong W; Dai K; Du J
Biomed Res Int; 2022; 2022():1263812. PubMed ID: 35832845
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
Liu X; Chu KM
J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
4. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis.
Zhang L; Li H; Yuan M; Li D; Sun C; Wang G
Dis Markers; 2020; 2020():2456340. PubMed ID: 32076458
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-122-5p inhibits tumorigenicity of gastric cancer by downregulating
Jiao Y; Zhang L; Li J; He Y; Zhang X; Li J
Int J Biol Markers; 2021 Mar; 36(1):36-46. PubMed ID: 33752480
[TBL] [Abstract][Full Text] [Related]
7. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
[TBL] [Abstract][Full Text] [Related]
8. Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells.
Chang L; Gao H; Wang L; Wang N; Zhang S; Zhou X; Yang H
Aging (Albany NY); 2021 Apr; 13(8):11808-11821. PubMed ID: 33883305
[TBL] [Abstract][Full Text] [Related]
9. Screening of non-invasive miRNA biomarker candidates for metastasis of gastric cancer by small RNA sequencing of plasma exosomes.
Zhang Y; Han T; Feng D; Li J; Wu M; Peng X; Wang B; Zhan X; Fu P
Carcinogenesis; 2020 Jul; 41(5):582-590. PubMed ID: 31740975
[TBL] [Abstract][Full Text] [Related]
10. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
11. Plasma exosomal
Chen L; Wang K; Li L; Zheng B; Zhang Q; Zhang F; Chen J; Wang S
Future Oncol; 2022 Aug; 18(26):2919-2931. PubMed ID: 35893704
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-423-5p targets SUFU to promote cancer growth and metastasis and serves as a novel marker for gastric cancer.
Yang H; Fu H; Wang B; Zhang X; Mao J; Li X; Wang M; Sun Z; Qian H; Xu W
Mol Carcinog; 2018 Sep; 57(9):1223-1236. PubMed ID: 29749061
[TBL] [Abstract][Full Text] [Related]
13. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
15. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer.
Wang L; Song X; Yu M; Niu L; Zhao Y; Tang Y; Zheng B; Song X; Xie L
Future Oncol; 2022 Mar; 18(7):793-805. PubMed ID: 34854318
[No Abstract] [Full Text] [Related]
16. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
[TBL] [Abstract][Full Text] [Related]
18. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
Mi Z; Gong L; Kong Y; Zhao P; Yin Y; Xu H; Tian L; Liu Z
Platelets; 2022 Nov; 33(8):1260-1269. PubMed ID: 35968647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
